Skip to main content
. 2016 Jul 13;2016(7):CD011272. doi: 10.1002/14651858.CD011272.pub2

Comparison 2. Rapamycin or rapalogs vs placebo (topical administration).

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Response to skin lesions 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
1.1 Rapamycin 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]